focus
drug
repurpos
known
approv
drug
lopinavirritonavir
report
fail
cure
infect
patient
urgent
gener
new
chemic
entiti
viru
key
enzym
lifecycl
coronaviru
main
proteas
pro
pro
attract
antivir
drug
design
base
recent
solv
structur
pdb
id
develop
novel
advanc
deep
qlearn
network
fragmentbas
drug
design
adqnfbdd
gener
potenti
lead
compound
target
pro
obtain
seri
deriv
lead
compound
structurebas
optim
polici
sbop
lead
compound
directli
aimodel
relat
deriv
base
sbop
access
molecular
librari
http
compound
use
potenti
candid
research
develop
drug
authorfund
right
reserv
reus
allow
without
permiss
biorxiv
preprint
diseas
worldwid
march
peopl
infect
peopl
report
dead
accord
john
hopkin
coronaviru
map
tracker
number
infect
death
still
increas
face
consider
threat
urgent
develop
new
inhibitor
drug
deadli
viru
unfortun
sinc
outbreak
sever
acut
respiratori
syndrom
sar
eighteen
year
ago
approv
treatment
sar
coronaviru
sarscov
similar
repurpos
potenti
drug
lopinavir
ritonavir
also
fail
inject
patient
structurebas
antivir
drug
design
new
artifici
intellig
algorithm
may
repres
help
approach
get
target
inhibitor
drug
thank
prompt
effort
mani
research
sever
piec
import
inform
vital
viru
genom
protein
structur
know
nonstructur
protein
main
proteas
pro
cystein
proteas
also
call
proteas
pro
moreov
know
structur
pro
similar
sarscov
sequenc
ident
structur
superposit
shown
figur
pro
report
attract
target
develop
anticoronavir
drug
proteas
highli
conserv
sequenc
structur
pro
key
enzym
relat
viru
includ
sar
replic
exist
viru
human
develop
specif
antivir
drug
target
pro
specif
viru
shown
signific
success
exampl
approv
drug
lopinavir
ritonavir
complet
occupi
substratebind
site
pro
break
replic
human
immunodefici
viru
hiv
howev
due
larg
differ
hiv
pro
lopinavir
ritonavir
valid
ineffect
inhibit
hand
substratebind
site
pro
almost
sar
figur
present
develop
potenti
inhibitor
drugdesign
experi
target
pro
may
also
applic
authorfund
right
reserv
reus
allow
without
permiss
emerg
coronaviru
caus
outbreak
coronaviru
exampl
recent
solv
structur
pro
pdb
id
indic
develop
inhibitor
coval
inhibitor
deriv
noncoval
inhibitor
sar
also
bind
pro
similar
bind
conform
figur
avail
inform
pave
way
design
new
target
coval
inhibitor
tci
success
tci
pro
must
first
abl
fit
bind
site
pro
appropri
pose
keep
reactiv
group
close
enough
undergo
chemic
step
nucleophil
attack
lead
format
stabl
coval
bond
present
scheme
tci
usual
longer
target
resid
time
rel
noncoval
inhibitor
theori
given
follow
inhibit
must
larger
thu
noncoval
bind
determin
equilibrium
constant
tci
chemic
reaction
step
target
usual
tci
bind
process
control
bigger
noncoval
inhibitor
extrem
case
henc
irrevers
inhibitor
coval
bind
target
target
disappear
consid
inhibitor
sar
pro
may
also
bioactiv
creat
molecular
librari
includ
report
pro
inhibitor
molecul
also
add
new
valid
molecular
structur
librari
research
progress
date
clinic
approv
vaccin
drug
specif
target
thu
hope
discov
novel
candid
drug
target
combin
artifici
intellig
ai
structurebas
drug
design
sbdd
acceler
gener
potenti
lead
compound
design
tci
ai
especi
deep
learn
appli
predict
molecular
properti
design
novel
molecul
unlik
earlier
deeplearn
molecular
design
ad
singl
atom
one
time
approach
explor
new
molecul
ad
meaning
molecular
fragment
one
one
comput
effici
also
chemic
reason
make
ai
model
work
well
first
step
prepar
molecular
fragment
librari
shown
figur
use
collect
sarscov
pro
inhibitor
molecul
initi
molecul
databas
target
pro
split
set
molecul
fragment
molecul
weight
dalton
collect
inhibitor
fragment
suppli
http
appli
advanc
deep
qlearn
network
fragmentbas
drug
design
adqnfbdd
gener
potenti
lead
compound
note
research
enough
experi
intern
lead
compound
bias
fragment
inject
inform
adqnfbdd
manual
ad
lead
compound
bias
fragment
correspond
file
use
fragment
directli
exist
bioactiv
molecul
adqnfbdd
agent
easili
access
potenti
chemic
space
focus
pro
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
adqnfbdd
automat
gener
novel
compound
target
new
viru
pro
obtain
coval
lead
compound
librari
uniqu
valid
structur
total
compound
select
high
score
aimodel
reward
function
molecul
evalu
dock
coval
dock
studi
lead
compound
high
coval
dock
score
attract
attent
also
low
differ
noncoval
coval
dock
pose
among
lead
compound
care
check
lead
interact
mode
pro
believ
still
much
space
optim
lead
design
seri
deriv
compound
base
chemic
biolog
knowledg
structurebas
optim
polici
gener
molecular
structur
publish
code
librari
http
encourag
research
interest
find
potenti
treatment
viral
infect
synthes
evalu
molecul
treat
solid
line
repres
taken
action
includ
additiondelet
differ
fragment
modif
step
dash
line
repres
action
reinforc
learn
agent
consid
make
first
three
action
fourth
action
exploratori
action
mean
taken
even
though
anoth
sibl
action
one
color
red
authorfund
right
reserv
reus
allow
without
permiss
tabl
kept
next
noncoval
dock
covalentdock
evalu
virtual
lead
display
suitabl
common
characterist
peptidomimet
proteinprotein
interact
ppi
inhibitor
mainli
rank
covalentdock
score
consid
covalentdock
also
contain
score
noncoval
dock
also
paid
attent
rmsd
differ
coval
bind
noncoval
bind
pose
base
heavi
atom
final
select
lead
molecul
display
figur
good
coval
dock
score
small
rmsd
valu
tabl
optim
get
seri
deriv
base
sbdd
approach
molecul
rank
number
base
coval
dock
score
interact
model
bind
site
care
check
shown
figur
although
compound
best
coval
dock
score
alert
group
aldehyd
consid
still
much
space
compound
fill
subsit
may
good
fit
oxyanion
hole
figur
pro
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
replac
aldehyd
formamid
also
replac
michael
acceptor
alphaketoamid
thu
optim
compound
compound
figur
b
figur
lead
compound
gener
ai
noncoval
molecular
dock
model
pro
brown
surfac
bound
lead
compound
magenta
stick
triazol
ring
bind
subsit
catalyt
activ
center
coval
fragment
aldehyd
bind
subsit
ring
bind
subsit
chromon
bind
subsit
b
twodimension
view
nonbond
interact
lead
compound
complex
proteas
base
noncoval
dock
triazol
ring
ie
ketoamid
phenol
hydroxi
form
hydrogen
bond
hbond
respect
c
coval
dock
model
compound
green
stick
proteas
brown
surfac
exhibit
similar
dock
model
noncoval
dock
view
ligand
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
interact
compound
proteas
coval
dock
triazol
ring
form
hbond
fragment
aldehyd
form
coval
bond
ie
key
residu
catalyt
center
proteas
result
coval
inhibit
aldehyd
carbonyl
form
hbond
besid
hydroxyl
chromon
posit
form
hbond
nonbond
interact
compound
pro
mainli
hydrogen
bond
carbonyl
group
coval
scaffold
form
hbond
hydrogen
acceptor
hydrogen
donor
hydrogen
nitrogen
atom
triazol
ring
form
hbond
also
form
hbond
carbonyl
group
main
chain
oxygen
ring
form
hbond
order
enhanc
polar
compound
sulfon
group
introduc
replac
keton
carbonyl
group
main
chain
sulfonamid
obtain
coval
dock
model
compound
pro
shown
figur
c
order
make
compound
fit
activ
pocket
higher
affin
ad
carbon
atom
sulfon
acid
group
origin
molecul
extend
carbon
chain
increas
flexibl
molecul
obtain
anoth
optim
compound
mode
coval
dock
pro
shown
figur
due
introduct
carbon
atom
enhanc
molecular
flexibl
ring
insert
deeper
pocket
fragment
compound
better
adapt
subsit
carbon
compound
form
coval
bond
key
residu
proteas
main
nonbond
interact
still
hydrogen
bond
indic
yellow
dash
triazol
ring
mainli
form
hbond
residu
pocket
coval
bind
fragment
mainli
form
hbond
key
amino
acid
residu
subsit
form
oxyanion
hole
red
circl
figur
side
chain
mainli
form
hbond
residu
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
pocket
chromon
scaffold
mainli
form
hbond
key
residu
pocket
addit
oxygen
sulfonyl
group
main
chain
form
hbond
pocket
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
repres
select
figur
display
may
evalu
molecular
dynam
simul
get
bind
free
energi
quantum
chemic
calcul
get
reaction
energi
barrier
meanwhil
chosen
candid
chemic
synthesi
activ
test
ongo
copyright
holder
preprint
peerreview
effici
effect
adqnfbbd
molecular
fragmentbas
grow
knowledg
chemic
reaction
model
atombas
rule
chemic
reaction
adqnfbdd
highli
flexibl
userfriendli
medicin
chemist
easili
inject
drug
discoveri
experi
reward
function
guid
novel
molecul
gener
adqnfbdd
relat
pipelin
use
design
drug
also
structurebas
drug
discoveri
especi
emerg
infeti
diseas
requir
treatment
time
intuit
problem
chemic
structur
graph
gener
formul
learn
reinforc
agent
perform
discret
action
chemic
reactionbas
fragment
addit
remov
chemistryawar
markov
decis
process
mdp
ac
denot
set
action
describ
modif
made
current
molecul
structur
time
step
action
classifi
three
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
categori
fragment
addit
fragment
delet
modif
probabl
specifi
next
possibl
state
given
current
state
action
time
step
defin
state
transit
determinist
exampl
figur
indic
ad
fragment
next
state
new
structur
ad
probabl
r
reward
function
specifi
reward
reach
state
discount
factor
typic
studi
framework
state
alway
valid
complet
chemic
structur
step
figur
indic
reward
given
termin
state
step
intermedi
reward
final
reward
use
guid
behavior
reinforc
learn
rl
agent
delay
spars
reward
issu
mani
reinforc
framework
suffer
furthermor
ensur
last
state
reward
use
tt
discount
valu
reward
state
addit
reward
function
directli
integr
experi
medicin
chemist
exampl
given
core
interest
medicin
chemist
may
add
bias
fragment
interest
input
use
design
reward
function
give
high
reward
signal
valu
bias
fragment
adqnfbdd
may
better
chanc
gener
desir
structur
rl
framework
chemic
environ
receiv
action
agent
emit
scalar
reward
rt
state
agent
figur
show
note
definit
environ
state
differ
gener
approach
environ
state
environ
privat
represent
invis
agent
defin
state
chemic
environ
intermedi
gener
molecul
structur
time
step
fulli
observ
rl
agent
simpli
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
environ
state
agent
state
task
molecul
gener
environ
incorpor
rule
chemistri
studi
chemistri
rule
basic
chemic
valenc
also
rule
ad
remov
fragment
deriv
known
inhibitor
base
chemic
reaction
detail
inform
defin
chemic
reaction
rule
present
tabl
indic
figur
expect
within
polici
state
st
taken
r
e
e
denot
reward
step
n
valu
function
q
st
measur
valu
take
action
state
st
v
st
valu
state
st
mean
good
state
obvious
v
st
seen
part
q
st
rest
part
q
st
defin
socal
advantag
function
st
intuit
advantag
valu
show
advantag
select
action
rel
other
given
state
eqn
rewritten
accord
eqn
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
note
come
duel
qnetwork
figur
indic
ac
size
action
space
make
rl
agent
robust
stabl
learn
handl
problem
overestim
qvalu
doubl
qnetwork
fix
qtarget
also
incorpor
td
temporaldiffer
e
anoth
duel
dqn
network
target
network
paramet
keep
fix
copi
duel
dqn
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
everi
step
use
updat
paramet
duel
dqn
figur
display
train
rl
agent
minim
loss
function
e
expect
loss
disadvantag
tendenc
domin
outlier
use
huber
loss
loss
function
priorit
experi
replay
per
techniqu
enabl
reinforc
learn
agent
rememb
reus
experi
past
replay
import
transit
frequent
per
use
replay
less
frequent
experi
use
code
priorit
replay
buffer
open
ai
gym
version
final
rl
agent
doubl
duel
deep
q
learn
fix
qtarget
priorit
experi
replay
fragmentbas
approach
drug
discoveri
fbdd
establish
effici
tool
search
new
drug
idea
fbdd
proper
optim
uniqu
interact
bind
site
subsequ
incorpor
singl
molecular
entiti
produc
compound
bind
affin
sum
individu
interact
howev
wide
use
fragment
librari
consid
divers
fragment
zinc
fragment
databas
low
probabl
exhibit
desir
bioactiv
given
protein
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
combin
idea
fbdd
rl
framework
first
collect
built
pro
inhibitor
dataset
contain
report
molecul
use
improv
bric
algorithm
studi
identifi
variou
scaffold
core
structur
privileg
characterist
term
activ
certain
target
core
structur
select
start
point
scaffoldbas
drug
discoveri
choos
design
proper
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
initi
scaffold
never
trivial
medicin
chemist
may
need
enough
experi
get
skill
luckili
serval
report
privileg
core
structur
target
sar
pro
chose
start
core
figur
display
core
valid
gener
coval
bond
sar
pro
report
rl
method
use
complet
structur
inform
posit
drug
inhibitor
templat
design
reward
function
rl
agent
learn
regener
templat
structur
gener
highli
similar
structur
templat
way
may
use
test
perform
rl
method
suitabl
realworld
drug
design
one
know
complet
structur
inform
novel
molecul
practic
approach
learn
structur
featur
exist
drug
inhibitor
local
focus
chemic
space
specif
protein
target
instead
simpli
put
attent
divers
molecul
structur
explor
possibl
gener
novel
molecul
base
exist
knowledg
design
deep
reinforc
learn
reward
drlreward
function
consist
final
properti
score
contain
specif
fragment
csf
score
pharmacophor
score
yez
repres
weight
quantit
estim
druglik
qed
properti
default
valu
yez
stand
qed
qed
valu
rang
properti
unfavour
properti
favour
calcul
eight
molecular
properti
score
function
contain
specif
fragment
csf
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
pocket
shown
surfac
assign
green
red
magenta
cyan
b
key
residu
bind
site
display
green
red
magenta
cyan
line
pictur
bind
site
gener
use
pymol
http
wwwpymolorg
bind
site
pro
figur
commonli
divid
catalyt
activ
center
specifi
sever
subsit
defin
subsit
may
favor
bind
fragment
gener
structur
includ
intermedi
contain
favor
fragment
equival
give
addit
reward
rl
agent
ze
control
contribut
bias
fragment
reward
signal
default
valu
stand
mani
bias
fragment
match
one
gener
structur
z
number
bias
fragment
defin
base
knowledg
learn
relat
work
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
repres
score
function
pharmacophor
mainli
depend
ligandprotein
interact
mode
crystal
structur
pdb
id
pharmacophor
plot
ad
figur
control
contribut
pharmacophor
score
reward
default
valu
discuss
reward
design
part
reward
function
consid
molecular
descriptor
threshold
qed
defin
pharmacophor
bias
fragment
total
uniqu
valid
structur
automat
gener
match
defin
rule
use
adqnfbdd
without
pretrain
mani
method
need
next
molecul
high
deep
reinforc
learn
score
drl
score
r
kept
molecul
uniqu
molecul
prepar
gener
least
conform
local
energi
minim
use
forc
field
ligand
prepar
modul
softwar
uniqu
molecul
gener
total
conform
dock
substratebind
site
pro
consid
balanc
precis
calcul
time
standprecis
sp
glide
firstli
use
predict
possibl
noncoval
bind
pose
bind
site
bind
site
grid
center
origin
ligand
buffer
dimens
follow
noncoval
dock
also
calcul
coval
dock
pose
score
molecul
reorder
dock
result
mainli
base
coval
dock
score
rmsd
valu
coval
dock
pose
noncoval
tabl
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
